Korea United Pharm said it recently won the Taiwan Intellectual Property Office’s recognition of the patent of Cilostan CR Tab. (cilostazol), an incrementally modified drug for intermittent claudication.The patent guarantees the Korean company’s exclusive rights to cilostazol sustained release techn
Medytox said that the Korea Drug Development Fund (KDDF) has selected Bruton's tyrosine kinase (BTK) inhibitor-based anticancer drug MT106 development project as a new national drug development project.The national new drug development project is a cross-ministerial R&D project established to secure
The Korean government should improve the regulatory regime to introduce decentralized clinical trials (DCT) to cope with the new environment for developing drugs, as seen during the Covid-19 pandemic, foreign experts said on Wednesday.Medidata, a company leading the digital transformation of life sc
Daewoong Pharmaceutical's botulinum toxin product Nabota marked the record-high sales records in two consecutive quarters in North America, the company said on Thursday.Daewoong’s local partner Evlous markets Nabota under the product name Jeuveau in North America.According to Evlous, Nobota attained
Sanofi-Aventis Korea said Thursday that its monoclonal antibody dupilumab has shown positive outcomes in each phase 3 clinical trial on adults with prurigo nodularis and patients above 12 with eosinophilic esophagitis.In phase 3 PRIME2 trial, dupilumab significantly reduced itching and skin lesions
Daewon Pharmaceutical has joined a race to develop an oral Covid-19 treatment. Daewon’s investigational drug aims to treat serious cases of Covid-19 infection while other oral drug candidates target mild ones.The company said on Tuesday that the Ministry of Food and Drug Safety granted the nod for a
A joint research team of Korea Basic Science Institute (KBSI) and Incheon National University has created a platform for developing therapies for brain cancer, known as an incurable disease.The research team expects the platform will allow small cell chips to examine the interaction between glioblas
GC Labcell and GC Cell announced a new start as an integrated corporation GC Cell on Tuesday.Its stock will be traded under the name of GC Cell from Nov. 17.The merged company aims to create synergy between the organic combination and utilization of GC Labcell's cell therapy research and process tec
Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, following four similar studies in the past two years.The company had won the go-ahead to run four phase 1 clinical trials of its combo therapy candidate bef
inno.N’s gastroesophageal reflux disease (GERD) treatment K-CAB (tegoprazan) will be covered by health insurance to treat gastric ulcer, which is the third indication after erosive and non-erosive GERD.K-CAB received the marketing license for four indications in Korea – erosive GERD, non-erosive GER
Handok Pharmaceuticals has decided to conduct a clinical trial of ABL001, or CTX-009, a bispecific antibody targeting cancer cells, in the U.S. with its local partner, Compass Therapeutics.The two companies plan to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Admini
GC said Tuesday that the European Medicines Agency (EMA) has granted orphan drug designation (ODD) to Hunterase ICV (intracerebroventricular), its treatment of severe hunter syndrome using a ventricular injection.The EMA based its decision on the clinical data of Hunterase ICV, which showed that it
JW Pharmaceutical said Tuesday that its dyslipidemia drug Rivaro (ingredient: pitavastatin) induced fewer side effects, such as diabetes, than other statin drugs through a study conducted in Taiwan.Researchers compared the cumulative risk of developing diabetes, hepatitis, and myopathy among partici
While Korean pharmaceutical and biotech companies have been slow to develop Covid-19 treatments, some continue developing Covid-19 drugs using natural ingredients.Industry watchers pay attention to whether they can complete drug development because it is not easy to recruit trial participants amid a
CubeBio, a company specializing in vitro diagnostics for early cancer detection, has advanced to the Russian market by signing an export contract.On Monday, the company said it signed an export contract with Russia’s Standart-Biotest and an investment agreement with the European Union at the Federat
EuBiologics said it has completed phase 3 clinical trials of its originally developed vaccine, EuTCV, against typhoid fever conducted in the Philippines.The company has been conducting studies to verify the efficacy of the typhoid vaccine in 444 healthy people aged six months to 45 years with De La
The government has begun to discuss granting health insurance benefits for an antidiabetic combination therapy combining dipeptidyl-peptidase 4 (DPP4) and sodium-glucose cotransporter-2 (SGLT2) inhibitors, touching off a competition among local drugmakers to join the market.Ildong Pharmaceutical rol
Korean pharmaceutical companies received lower ratings than non-pharma businesses in the environment section in their environmental, social, and governance (ESG) performance, according to the Korea Corporate Governance Service (KCGS).To address this problem, they should check ESG issues regularly an
Hanmi Pharmaceutical has commercialized its first new biomedicine, Rolontis (ingredient: eflapegrastim), a long-acting neutropenia treatment and Korea's 33rd novel drug.Hanmi said on Monday that it expects Rolontis to provide new options for a prophylactic prescription that can restore abnormally de
Researchers have expressed different opinions on why the U.S. FDA requested Amgen conduct a low-dose trial of Lumakras (sotorasib), the first Kras G12C inhibitor to treat cancer.The latest issue of the Journal of Clinical Oncology (KCO), a journal by the American Society of Clinical Oncology (ASCO),